ReNeuron Group plc
RNUGF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $10 | $15 | $13 |
| Short-Term Investments | $1 | $5 | $8 | $0 |
| Receivables | $1 | $1 | $0 | $1 |
| Inventory | -$2 | -$2 | $0 | -$7 |
| Other Curr. Assets | $3 | $3 | $2 | $12 |
| Total Curr. Assets | $9 | $16 | $24 | $19 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10 | $17 | $25 | $20 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$6 | $0 | -$4 |
| Other Curr. Liab. | $4 | $12 | $5 | $8 |
| Total Curr. Liab. | $4 | $7 | $6 | $6 |
| LT Debt | $0 | $0 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $5 | $7 | $6 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $0 |
| Retained Earnings | -$152 | -$147 | -$138 | -$128 |
| AOCI | $40 | $40 | $0 | $40 |
| Other Equity | $116 | $116 | $156 | $138 |
| Total Equity | $5 | $10 | $19 | $13 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10 | $17 | $25 | $20 |
| Net Debt | -$6 | -$9 | -$14 | -$12 |